Chinmay Jani: The impact of irAEs on survival outcomes in a racially diverse cohort of NSCLC
Chinmay Jani, Hematology and Oncology Fellow at University of Miami, posted on X about recent paper by him as co-author, titled “The impact of immune-related adverse events on survival outcomes in a racially diverse population, with a focus on non-Hispanic Black patients” published on The Oncologist.
Authors: Amr Radwan, Chinmay T Jani, Omar Al Omari, Mohini Patel, Laura Burns, Zoe Mackay, Liuping Li, Kiana Mahdaviani, Arielle Davidson, Janice Weinberg, Peter C Everett, Kei Suzuki, Kimberley S Mak, Matthew H Kulke, Umit Tapan.
“Our recent study in The Oncologist examines the impact of irAEs on survival outcomes in a racially diverse cohort of NSLC, focusing on non-Hispanic Black individuals.
We found that patients who developed irAEs experienced significantly improved survival outcomes.
This association remained independent of race and ethnicity, underscoring the importance of providing unbiased treatment recommendations.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023